SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-19-002916
Filing Date
2019-04-25
Accepted
2019-04-25 14:15:22
Documents
46
Period of Report
2018-05-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT plsi-10q_053118.htm 10-Q 278184
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 17605
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 17743
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 7127
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 7051
  Complete submission text file 0001387131-19-002916.txt   2022459

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plsi-20180531.xml EX-101.INS 251160
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plsi-20180531.xsd EX-101.SCH 29536
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plsi-20180531_cal.xml EX-101.CAL 32346
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plsi-20180531_def.xml EX-101.DEF 128210
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plsi-20180531_lab.xml EX-101.LAB 204620
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plsi-20180531_pre.xml EX-101.PRE 165187
Mailing Address 3000 LAWRENCE STREET DENVER CO 80205
Business Address 3000 LAWRENCE STREET DENVER CO 80205 1.720.699.7222
Phoenix Life Sciences International Limited. (Filer) CIK: 0001493212 (see all company filings)

IRS No.: 460525378 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 333-167275 | Film No.: 19766864
SIC: 1311 Crude Petroleum & Natural Gas